Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogens, toxins, and autoantigens represent a broad pharmacological category rather than a single molecular target. This classification, utilized by resources such as the IUPHAR/BPS Guide to Pharmacology, encompasses non-host biological entities (bacteria, viruses, fungi, and parasites), biochemical poisons (venoms and microbial toxins), and endogenous host molecules that become the target of an aberrant immune response (autoantigens) [1]. Pathogens are typically targeted by anti-infective agents that exploit differences between host and pathogen biology, such as bacterial cell wall synthesis or viral reverse transcription [2]. Toxins are addressed through neutralizing agents like antitoxins or chelators that prevent the substance from interacting with host receptors [1]. Autoantigens are the focus of therapies for autoimmune diseases, where the goal is to deplete the B-cells producing autoantibodies or to interfere with the antigen-presentation process [3]. Because this entry describes a high-level grouping of diverse biological and chemical threats, it is considered a category of targets rather than a specific protein or receptor [1].
Therapeutic intervention involves the neutralization of toxins, inhibition of pathogen replication (e.g., cell wall synthesis or viral protease inhibition), or the modulation/suppression of the immune response against self-derived autoantigens.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogens, toxins, and autoantigens.